Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3761-3766

  Hrašćan, Reno ^a   Pavelić, Krešimir ^a   Pavičić, Dino ^a   Križanac, Šimun ^b   Štajcer Štitić, Vesna ^b   Pečur, Lada ^c   Spaventi, Šime ^a   Klimpfinger, Martin ^c   Pavelić, Jasminka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

c N ras; Neuroendocrine tumor; Oncogenes; p53; Point mutations

Indexed keywords

ADENINE; ARGININE; CALCITONIN; CHROMOGRANIN; CYTOKERATIN; CYTOSINE; DNA; GLUCAGON LIKE PEPTIDE 1; GLYCINE; GUANINE; LYSINE; PROTEIN P53; SERINE; SYNAPTOPHYSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CODON; CONTROLLED STUDY; DNA HYBRIDIZATION; GENE ACTIVATION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; METASTASIS; NEUROENDOCRINE TUMOR; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE C H RAS; PANCREAS TUMOR; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

GENES, P53; GENES, RAS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; POINT MUTATION; RAS PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030499480     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kent RB, Van Heerden JA and Weiland LH: Non-functioning islet cell tumors. Ann Surg 193: 185-190, 1981.
2. Tong-Hua Yu Z, Quan-Cai C, Li-Xing C, Sheng-Feng Y, Shou-Xian Z and Hong-Ping J: Nonfunctioning pancreatic endocrine tumors. An immunohistochemical and electron microscopic analysis of 26 cases. Path Res Pract 188: 191-198, 1992.
3. Carty SE, Jensen RT and Norton JA: Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112: 1024-1032, 1992.
4. Poston GJ, Gillespie J and Guillon PJ: Biology of pancreatic cancer. Gut 32: 800-812, 1991.
5. Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Kruslin B, Belicza M and Cabrijan T: Multiple genetical alterations in malignant metastatic insulinomas. J Pathol 177: 395-400, 1995.
6. Heitz PU, Kasper M, Polak JM and Kloppel G: Pancreatic endocrine tumors: immunocytochemical analysis of 125 tumors. Hum Pathol 13: 263-271, 1982.
7. Mukai K, Grotting JC, Greider MH and Rosai J: Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 6: 387-399, 1982.
8. Pavelic K, Pavelic ZP, Denton D, Reising J, Khalily M and Preisler HD: Immunohistochemical detection of C-MYC oncoprotein in paraffin embedded tissue. J Exp Pathol 5: 143-153, 1990.
9. Pavelic K, Pavelic ZP and Preisler HD: C-MYC detection in bone marrow biopsies. Leukemia Res 15: 1075-1078, 1991.
10. Gall K, Pavelic J, Jadro-Santel D, Poljak M and Pavelic K: DNA amplification by polymerase chain reaction from brain tissues embedded in paraffin. Int J Exp Pathol 74: 333-337,1993.
11. Verlaan-de Vries M, Bogaard ME, van den Elst H, van Boom JH, van der Eb AJ and Bos JL: A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 50: 313-320, 1986.
12. Buchman VL, Chumakov DM, Ninkina NN, Samarina OP and Georgiev GPA: Variation in the structure of the protein-coding region of the human p53 gene. Gene 70: 242-245, 1988.
13. McCabe IC: Production of single strended DNA by asymmetric PCR. In: PCR Protocols. A Guidline for Methods and Applications (Innis MA, Gelfand OH, Sninsky JY, White TJ, eds). Academic Press, 1990, pp 76-83.
14. Innis MA, Myambo KB, Gelfand DH and Brow MA: DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction amplified DNA. Proc Natl Acad Sci USA 85: 9436-9440, 1988.
15. Ballsa K, Lyons J, Janssen JWG and Bartram CR:. Incidence of ras gene mutaions in neuroblastoma. Eur J Pediatr 147: 313-314, 1988.
16. Ireland CM: Activated N-ras oncogenes in human neuroblastoma. Cancer Res 49: 5530-5533, 1984.
17. Moley JF, Brother MB, Wells SA, Splengler BA, Biedler JL and Brodeur GM: Low frequency of ras gene mutations in neuroblastoma. pheochromocytomas, and medullary thyroid cancers. Cancer Res 51: 1596-1599, 1991.
18. Han HJ, Yanagisawa A, Kato Y, Park JG and Nakamura Y: Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53: 5087-5089, 1993.
19. Arany I, Rady P, Evers BM, Tyring SK and Townsend CM: Analysis of multiple molecular changes in human endocrine tumors. Surg Oncol 3: 153-159, 1994.
20. Yoshimoto K, Iwanaha H, Fukuda A, Sano T, Saito S and Itakura M: Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res 52: 5061-5064, 1992.
21. Bressac B, Kew M, Wands J and Ozturk M: Selective G to T mutations of. p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431, 1991.
22. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427-428, 1991.
23. Karga H., Lee J-K, Vickery AL, Thor A, Gaz RD and Jameson JL: ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab 73: 832-836, 1991.
24. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele specific oligonucleotide hybridization. Am J Pathol 143: 545-554, 1993.
25. Barbacid M: ras genes. Annu Rev Biochem 56: 779-827, 1987.
26. Boukaps P, Stanbridge EJ, Yin Foo D, Cerutti PA and Fusenig NE: c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo hut lacks correlation with malignancy. Cancer Res 50: 2840-2847, 19911.
27. Cales C, Hancock JF, Marshall CJ and Hall A: The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature 332: 548-551,1988.
28. Gherzi R, Briata P, Fehman HC and Goke B: ras antagonizes cAMP stimulated glucagon gene transcription in pancreatic islet cell lines. FEBS Letters 353: 277-280,1994.
29. Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme T, G. Yang G, Scardino PT and Thompson TC: DNA ploidy and clonal selection in ras + myc- induced mouse prostate cancer. Int J Cancer 60: 395-399, 1995.